A cisplatin‑incorporated liposome that targets the epidermal growth factor receptor enhances radiotherapeutic efficacy without nephrotoxicity.
暂无分享,去创建一个
E. Choi | Y. Suh | J. Hwang | Joohee Jung | S. Kuroda | Jaesook Park | Inki Kim | S. Park | S. Song | Jung Shin Lee | Seong-Yun Jeong | Jinhyang Choi | E. Ju | Seol Hwa Shin | Seong‐Yun Jeong | Jung Shin Lee | Jae Hee Lee
[1] International Journal of Oncology , 2017 .
[2] W. Hennink,et al. Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[3] E. Choi,et al. c-Myc down-regulation is involved in proteasome inhibitor-mediated enhancement of radiotherapeutic efficacy in non-small cell lung cancer. , 2011, International journal of oncology.
[4] Rohit Kolhatkar,et al. Active tumor targeting of nanomaterials using folic acid, transferrin and integrin receptors. , 2011, Current drug discovery technologies.
[5] P. Baas,et al. Chemoradiation therapy in nonsmall cell lung cancer , 2011, Current opinion in oncology.
[6] S. Dirkes. Acute kidney injury: not just acute renal failure anymore? , 2011, Critical care nurse.
[7] Kristina M Yaklin. Acute kidney injury: an overview of pathophysiology and treatments. , 2011, Nephrology nursing journal : journal of the American Nephrology Nurses' Association.
[8] M. Thanou,et al. Targeting nanoparticles to cancer. , 2010, Pharmacological research.
[9] E. Graves,et al. The tumor microenvironment in non-small-cell lung cancer. , 2010, Seminars in radiation oncology.
[10] D. Salomon,et al. Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells. , 2010, International journal of pharmaceutics.
[11] S. Yoon,et al. Systemic delivery and preclinical evaluation of Au nanoparticle containing beta-lapachone for radiosensitization. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[12] Ching-Li Tseng,et al. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. , 2009, Biomaterials.
[13] Zonghai Li,et al. Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo. , 2008, International journal of pharmaceutics.
[14] Kunihiro Tsuchida,et al. Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns. , 2008, ACS nano.
[15] R. Weaver,et al. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway. , 2008, Toxicology.
[16] L. Marks,et al. Radiation-induced lung injury. Assessment, management, and prevention. , 2008, Oncology.
[17] L. Zambolim,et al. Synthesis and Antifungal Activity of Aromatic Bis‐γ‐lactones Analogous to Avenaciolide , 2007 .
[18] K. Nugent,et al. Cisplatin Nephrotoxicity: A Review , 2007, The American journal of the medical sciences.
[19] Mechthild Krause,et al. EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] M. Hirai,et al. Accumulation of liposome with Sialyl Lewis X to inflammation and tumor region: application to in vivo bio-imaging. , 2007, Biochemical and biophysical research communications.
[21] G. Giaccone. Twenty-five years of treating advanced NSCLC: what have we achieved? , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] Y. Sugiyama,et al. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. , 2003, Cancer research.
[23] K Kian Ang,et al. The epidermal growth factor receptor mediates radioresistance. , 2003, International journal of radiation oncology, biology, physics.
[24] M. Bally,et al. Antibody conjugation methods for active targeting of liposomes. , 2000, Methods in molecular medicine.
[25] D. Papahadjopoulos,et al. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.
[26] P. Beaumier,et al. Uptake of small liposomes by non-reticuloendothelial tissues. , 1987, Biochimica et biophysica acta.